Depression indicators predict work disabilty more than disease activity or response to therapy

June 13, 2013, European League Against Rheumatism

Data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, demonstrate that indicators of depression are stronger predictors of work disability in early arthritis than disease activity or response to therapy.

The study showed that in a none of the arthritis activity measures or cardiovascular, metabolic or pulmonary diseases investigated were associated with early retirement, yet a single depression statement "having little pleasure or interest in doing things most of the days during the past 2 weeks" identified those patients more likely to request disability pension.

"Our findings demonstrate that whether or not patients with early arthritis consider applying for disability pension is more dependent on mental conditions than disease activity. As arthritis has a significant financial impact on patients and society, well-directed attention on well-being in the early stages of disease may help patients remain in the workforce", commented lead author of the study Professor Angela Zink, Head of the Epidemiology Unit at the German Rheumatism Research Centre in Berlin.

Musculoskeletal diseases affect at least 100 million people in Europe, accounting for one half of all European absences from work and 60% of work incapacity. If inadequately managed, they represent a significant economic burden on European society, estimated to be up to 2% of GDP.2

573 patients <63 years enrolled in an early inflammatory arthritis (IA) cohort (<6 months) were analysed with respect to their decision to request disability pension within the first 12 months of treatment. Patient reported parameters included pain, morning stiffness, fatigue, functional capacity, and the depression statement "having little pleasure or interest in doing things most of the day.

Patients had symptom duration of 13 +7 weeks, 67% were rheumatoid factor (RF) and/or anti-citrullinated protein antibody (ACPA)-positive, 65% fulfilled the new ACR-EULAR RA criteria* at baseline and 87% took disease-modifying (DMARDs) at 12 months. Within one year of care, 21% of patients with indicators of and 45% of those with had considered or entered .

Explore further: Brodalumab demonstrates significant clinical response in psoriatic arthritis

More information: * ACR-EULAR criteria: diagnosis based on confirmed synovitis in at least 1 joint, absence of alternative diagnosis to explain synovitis, and achievement of a total score of >6 (0-10) from individual scores in 4 domains: number and site of involved joints (0), serologic abnormality (0), elevated acute-phase response (0), and symptom duration (2 levels; 0)

1.Westhoff G et al., Indicators of depression are stronger predictors of work disability in early arthritis than disease activity or response to therapy [abstract]. EULAR Annual European Congress of Rheumatology; 12-15 June 2013; Madrid, Spain. Abstract nr. OP0092.

2.Making work count – how Health Technology Assessment can keep Europeans in work. A Fit for Work Europe paper, 2012. Available from: www.fitforworkeurope.eu/Making … ork_FULL%20PAPER.pdf. Last accessed: 16 June 2013

Related Stories

Brodalumab demonstrates significant clinical response in psoriatic arthritis

June 12, 2013
A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism, shows that treatment with brodalumab demonstrates significant clinical response and an acceptable safety profile in ...

Long-term apremilast demonstrates continued efficacy in patients with psoriatic arthritis

June 12, 2013
New data presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism show that apremilast administered to patients with psoriatic arthritis continues to demonstrate meaningful clinical responses ...

Significant improvements in psoriatic arthritis with ustekinumab

June 12, 2013
New PSUMMIT 2* data first presented at EULAR 2013, the Annual Congress of the European League Against Rheumatism, further demonstrate the efficacy of ustekinumab in Psoriatic Arthritis (PsA).

Not all patients benefit equally from hip or knee replacement, study finds

April 4, 2013
Only half of people with arthritis who had a hip or knee replacement reported a significant improvement in pain and mobility after surgery, according to a new study led by Women's College Hospital and the Institute for Clinical ...

Ultrasound findings can improve classification of RA

May 15, 2013
(HealthDay)—Compared to clinical diagnosis of synovitis, ultrasound-detected synovitis provides either improved sensitivity or specificity when used with the American College of Rheumatology/European League Against Rheumatism ...

CHERISH trial demonstrates efficacy of tocilizumab in juvenile idiopathic arthritis

June 12, 2013
A new study presented today at EULAR 2013, the Annual Congress of the European League Against Rheumatism shows that tocilizumab is efficacious and leads to a sustained clinically meaningful improvement in children with polyarticular ...

Recommended for you

Osteoarthritis could be treated as two diseases, scientists reveal

January 10, 2018
Scientists at The University of Manchester have discovered that most people with osteoarthritis can be subdivided into two distinct disease groups, with implications for diagnosis and drug development.

US arthritis prevalence is much higher than current estimates

November 27, 2017
New research indicates that the prevalence of arthritis in the United States has been substantially underestimated, especially among adults

Maintaining sufficient vitamin D levels may help to prevent rheumatoid arthritis

November 20, 2017
Maintaining sufficient vitamin D levels may help to prevent the onset of inflammatory diseases like rheumatoid arthritis, research led by the University of Birmingham has discovered.

Old World monkeys could be key to a new, powerful rheumatoid arthritis therapy

November 16, 2017
In the quest for a new and more effective treatment for rheumatoid arthritis, researchers from the Keck School of Medicine of USC looked to a primate that mostly roams the land in Asia, the Middle East and Africa. It was ...

Study lists foods for fighting rheumatoid arthritis symptoms and progression

November 8, 2017
A list of food items with proven beneficial effects on the progression and symptoms of rheumatoid arthritis is provided in a new study published today in Frontiers in Nutrition. The authors suggest incorporating these foods ...

Prototype equipment can detect rheumatoid arthritis

September 28, 2017
According to a first clinical study published in the scientific journal Photoacoustics, the University of Twente and various European partners have designed a device that shows the difference between healthy fingers and arthritic ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.